On a mission to champion investment within the impact investor and startup ecosystem, Spring Activator has announced the launch of the second Health Impact Investor Challenge.
In collaboration with the TELUS Pollinator Fund for Good, the challenge is set to run from April to June of 2023, and aims to connect healthcare founders with investors and support them in navigating the investment process and landscape.
The Challenge will culminate in $200,000+ invested into a prominent Canadian healthcare startup from investors across the country.
Last spring, the 2022 Health Impact Investor Challenge trained 33 angel investors, 15 healthcare companies, and culminated in $300,000 invested into UVX, a device company that disinfects air and surfaces using a form of light that is safe for human exposure but kills pathogens in seconds, even while people are present.
Other participating companies went on to raise $5+ million within six months of the program, with one healthcare finalist winning nearly $300,000 through the subsequent Spring Activator Women-led Impact Investor Challenge presented by the TELUS Pollinator Fund.
“Spring Activator is thrilled to continue collaborating with the TELUS Pollinator Fund to support the growing investor community,” said Kristen Perry, Managing Director at the Spring Investment Collective.
“Through collaborating with regional partners and empowering investors with a diversity of knowledge and networks in the sector, this program will be a unique opportunity for healthcare founders across Canada to not only access investment, but also tap into support and connection resources to scale their growth and impact.”
The top 15 venture applicants will be selected to participate in an 11 week program to learn and pitch alongside a cohort of investors. The investors will vote for the top five companies to present at the Grand Finale pitch event, where they will have the chance to win at least $200,000 in equity investment from the cohort.
Applications are open to any venture based in Canada who is an early-stage socially or environmentally driven venture in the healthcare industry looking to raise Seed or Series A capital and scale their impact.
Investors can also apply to be a part of the investor group and do not need to be accredited to participate.